Rockefeller Capital Management L.P. Genmab A/S Transaction History
Rockefeller Capital Management L.P.
- $36 Billion
- Q4 2024
A detailed history of Rockefeller Capital Management L.P. transactions in Genmab A/S stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 14,894 shares of GMAB stock, worth $317,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,894
Previous 16,174
7.91%
Holding current value
$317,242
Previous $394,000
21.32%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding GMAB
# of Institutions
236Shares Held
56.3MCall Options Held
25.3KPut Options Held
33.4K-
Alliancebernstein L.P. New York, NY14.9MShares$318 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$108 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$65.9 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$60 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$59.8 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...